Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior Penetration and Tolerability
Antikor Biopharma Limited (Antikor), a leader in developing and advancing Antibody Fragment-Drug Conjugates (FDCs), will be presenting new data at the 9th Protein and Antibody Engineering Summit (PEGS) Europe in Lisbon on 14th November, 2017 (www.pegsummiteurope.com). Dr Deonarain, CEO and CSO will present pivotal data that strengthens Antikor's conviction that its unique FDC platform is a superior approach to treating solid tumours, whilst further reducing the risk of liver, renal and haematological toxicities often associated with whole ADCs. Dr Deonarain commented, “The major issue about applying ADCs successfully in oncology is getting a wide enough therapeutic window in patients. Therapies that look promising in development often cannot be administered at high enough doses to drive the penetration into difficult-to-treat solid tumours. Our data suggest that we can widen this window by hitting solid tumours more effectively whilst sparing normal tissues".
Antikor's innovative small-format, platform technology uses specifically-engineered antibody fragments that combine the rapid and effective penetration into solid tumours with the faster clearance from normal organs. These FDCs can deliver higher quantities of cytotoxic agent more quickly than conventional larger whole Antibody Drug Conjugates (ADCs). New data will show that using two highly potent, clinically-validated cytotoxic payloads, FDCs are around 10-times better tolerated and less toxic than ADCs carrying the same quantity of payload. Furthermore, Antikor’s FDC platform can deliver at least 4-times more payload safely, giving a predicted therapeutic index enhancement of over 40x compared to an ADC. Dr Deonarain will also unveil Antikor’s novel FDC discovery engine, a toolbox for discovering effective FDCs to any target. These FDC-specific antibody libraries offer a valuable resource for the generation of a pipeline of future novel FDCs.
Dr Medinger, Antikor’s chairman is also presenting Antikor’s progress and commercial opportunities at the OBN-Eurasanté’s Bioseed showcasing event in London on 14th November, 2017 (https://bioseed.eu). He commented “Antikor has made great progress over the last year and is ready to take the next step towards commercializing its technology and progressing its lead product candidate for gastric cancer. This is a devastating disease and unmet clinical need which could ideally be tackled by our FDC technology”.
#Antikor, #FDCs, #Fragment Drug Conjugate, #PEGS Europe
Antikor Biopharma Limited
Dr Mahendra Deonarain
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Porta Solutions Has Been Awarded as Excellence of the Year Innovation & Leadership for the Flexible Production at Le Fonti Awards 201721.11.2017 20:04 | Tiedote
Maurizio Porta, Porta Solutions’CEO triumphed at the 32th edition of the IAIR Awards. The Award Ceremony, held at the at London Stock Exchange on the 20th of October 2017, crowned him the Excellence of the Year, Innovation & Leadership, for the Flexible Production. For being an Italian excellence since 1958, innovative leader in the sector of productive flexibility in the manufacturing world. In particular to be able to aim continually and strategically on innovation and customization to ensure the best performance and highest quality. “Flexible Production: produce what you sell, no stock, no stress, more cash" says Maurizio Porta. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005803/en/ Porta Solutions was awarded at the Le Fonti Awards (Photo: Business Wire) Today, the
China Global Investment Forum Hangzhou 2017 Opens21.11.2017 19:04 | Tiedote
On November 20, China Global Investment Forum Hangzhou 2017 opened. The forum was hosted by the Hangzhou Municipal People's Government and the Department of Commerce of Zhejiang Province, and organized by the Hangzhou Investment Promotion Bureau and Euromoney Institutional Investor PLC. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005723/en/ China Global Investment Forum Hangzhou 2017 Themed "Sharing the Opportunity of Hangzhou, Co-building a World-renowned City", the event brought together nearly 1,000 renowned experts, scholars and entrepreneurs from home and abroad, to interpret Hangzhou's economy, explore Hangzhou's future industries, look into the investment trends of the world and Hangzhou, and offer advice on improving Hangzhou's level of opening to the outside world, promoting
TechnipFMC, Saipem & Bureau Veritas Sign Partnership with Expert Teleportation21.11.2017 18:27 | Tiedote
BUREAU VERITAS, SAIPEM and TECHNIPFMC are teaming up to bring expert tele assistance to on-site operators within the specific context of the Oil & Gas sector (offshore, remote location, ATEX, IECEx, etc.) and have formed a collaborative partnership with EXPERT TELEPORTATION who will lead the project development. The 15-month long project will deliver a hands’ free device (modified smart glasses) adapted to use with personnel protective equipment. The adapted tool will connect an operator located on site anywhere in the world with a remote expert / analyst in real time via audio and video stream. This EXPERT TELEPORTATION project will enable higher operational efficiency, smarter and faster response time, improved safety and a reduced carbon footprint. ABOUT: In an increasingly competit
Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) from EMA in Newly Diagnosed Multiple Myeloma21.11.2017 17:40 | Tiedote
Janssen-Cilag International NV today announced the submission of a Type II variation application to the European Medicines Agency (EMA), for the immunotherapy DARZALEX®▼ (daratumumab). The application seeks to broaden the existing marketing authorisation to include daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. “This submission to health authorities takes us one step closer to our goal of redefining combination therapy in multiple myeloma, with the potential to make daratumumab available to more patients throughout the treatment continuum: from newly diagnosed, to heavily pre-treated,” said Dr Catherine Taylor, Haematology Therapeutic Area Lead, Janssen Europe, Middle East and Africa (EMEA). “We look forward to working closely with the
Andersen Global Announces Expansion in Uganda21.11.2017 17:30 | Tiedote
Andersen Global is proud to announce a presence in Uganda by way of a Collaboration Agreement with Ligomarc Advocates, a financial and corporate tax and legal firm. The firm is led by Managing Partner, Kabiito Karamagi. The addition of Ligomarc Advocates as a Collaborating Firm of Andersen Global continues the organization’s expansion in Africa. Ligomarc is Andersen Global’s fourth location in Africa. “Integrity, excellence, and putting the client at the center have always been of paramount importance to us, and our collaboration with Andersen Global will allow us to ensure our clients receive the best-in-class service internationally,” commented Kabiito Karamagi. “The team at Andersen shares our values of outstanding, seamless client service and independence—this is a natural fit.” Ligomarc Advocates was founded as a sole practice over fifteen years ago by Ruth Sebatindira,
Keio Plaza Hotel Tokyo Hosts "Sky Jazz Night" Events in the "Premier Grand" Club Lounge21.11.2017 17:00 | Tiedote
Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will host special jazz events for guests staying in our “Premier Grand” Club Floor on December 7, 8, 14, 15, and 16, 2017. A duo consisting of piano and contrabass artists will perform 30 minutes jazz sessions in our Club Lounge located on the 45th floor at 5:30p.m., 6:30p.m., and 7:30p.m. Guests listening to these jazz sessions can enjoy complimentary hors d’ oeuvres, and alcoholic and non-alcoholic beverages. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171121005017/en/ Club Floor "Premier Grand," Club Lounge (Photo: Business Wire) Our “Premier Grand” Club Floors were renovated and newly opened in December 2016, with guest rooms being fitted with various premium items
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme